Search Result

Cancer CancerType Treatment Signature SearchID Experimental PMID Details Boxplot Network Correlation Survival
HER2-Positive Breast CancerBRCATrastuzumabPD-1PDCD1clinical trail26842237Details
Inflammatory Breast CancerBRCACetuximabXIAPXIAPcell lines26821068Details
Inflammatory Breast CancerBRCACetuximabGPX3GPX3cell lines26821068Details
Inflammatory Breast CancerBRCACetuximabSRD5A1SRD5A1cell lines26821068Details
Inflammatory Breast CancerBRCACetuximabDHRS9DHRS9cell lines26821068Details
Breast CancerBRCACD73-siRNA-loaded ChLa NPsCD73NT5Ecell lines26733167Details
Breast CancerBRCAado-trastuzumab emtansineCXCL9CXCL9mouse model26606967Details
Breast CancerBRCAado-trastuzumab emtansineCCL3CCL3mouse model26606967Details
Breast CancerBRCAado-trastuzumab emtansineCCL4CCL4mouse model26606967Details
Breast CancerBRCAado-trastuzumab emtansineRANTESCCL5mouse model26606967Details
Breast CancerBRCAado-trastuzumab emtansineCXCL1CXCL1mouse model26606967Details
Breast CancerBRCAado-trastuzumab emtansineM-CSFCSF1mouse model26606967Details
Breast CancerBRCAado-trastuzumab emtansineVEGFVEGFAmouse model26606967Details
Triple Negative Breast CancerBRCAα-PD-1Ras-MAPK pathwayNAmouse model26515496DetailsNANANANA
Breast CancerBRCAAMG487CD3+ CD4+ T cellsCD4+ T cellmouse model26485767Details
Breast CancerBRCAAMG487CD3+ CD4+ T cellsCD4+ T helper cellmouse model26485767Details
Breast CancerBRCAAMG487CD3+ CD4+ T cellsCD4+CD25+ regulatory T cellmouse model26485767Details
Breast CancerBRCAAMG487CD3+ CD8+ T cellsExhausted CD8+ T cellmouse model26485767Details
Breast CancerBRCAAMG487CD3+ CD8+ T cellsCD8+ T cellmouse model26485767Details
Breast CancerBRCAAMG487CD3+ CD8+ T cellsCD8+ cytotoxic T cellmouse model26485767Details
Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4-CD28+ T cellclinical trial phase 129109077Details
Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4-CD28- T cellclinical trial phase 129109077Details
Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4+ T helper cellclinical trial phase 129109077Details
Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4+CD25+ regulatory T cellclinical trial phase 129109077Details
Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4+ cytotoxic T cellclinical trial phase 129109077Details
Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4+ T cellclinical trial phase 129109077Details
Triple Negative Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4-CD28+ T cellclinical trial phase 129109077Details
Triple Negative Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4-CD28- T cellclinical trial phase 129109077Details
Triple Negative Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4+ T helper cellclinical trial phase 129109077Details
Triple Negative Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4+CD25+ regulatory T cellclinical trial phase 129109077Details
Triple Negative Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4+ cytotoxic T cellclinical trial phase 129109077Details
Triple Negative Breast CancerBRCAc-Met RNA CAR T cellCD4+ T cellsCD4+ T cellclinical trial phase 129109077Details
Breast CancerBRCAc-Met RNA CAR T cellCD68+ macrophagesMacrophageclinical trial phase 229109077Details
Breast CancerBRCAc-Met RNA CAR T cellCD68+ macrophagesM2 macrophageclinical trial phase 229109077Details
Breast CancerBRCAc-Met RNA CAR T cellCD68+ macrophagesM1 macrophageclinical trial phase 229109077Details
Breast CancerBRCAAvelumabPD-L1CD274clinical trial phase 129063313Details
Breast CancerBRCAE7046CD4+ T cellsCD4-CD28+ T cellmouse model28920002Details
Breast CancerBRCAE7046CD4+ T cellsCD4-CD28- T cellmouse model28920002Details
Breast CancerBRCAE7046CD4+ T cellsCD4+ T helper cellmouse model28920002Details
Breast CancerBRCAE7046CD4+ T cellsCD4+CD25+ regulatory T cellmouse model28920002Details
Breast CancerBRCAE7046CD4+ T cellsCD4+ cytotoxic T cellmouse model28920002Details
Breast CancerBRCAE7046CD4+ T cellsCD4+ T cellmouse model28920002Details
Breast CancerBRCAE7046granzyme B+ CD8+ T cellsCD8+ cytotoxic T cellmouse model28920002Details
Breast CancerBRCAE7046granzyme B+ CD8+ T cellsEffector CD8+ memory T (Tem) cellmouse model28920002Details
Breast CancerBRCAE7046M1-like macrophagesM1 macrophagemouse model28920002Details
Breast CancerBRCAE7046M2-like macrophagesM2 macrophagemouse model28920002Details
Triple Negative Breast CancerBRCApoly(I:C)PD-L1CD274mouse model28848054Details
Triple Negative Breast CancerBRCApoly(I:C)CD69+/NKG2D+ CD4+ T CellNAmouse model28848054Details
Triple Negative Breast CancerBRCApoly(I:C)CD69+/NKG2D+ CD8+ T CellNAmouse model28848054Details
Triple Negative Breast CancerBRCApoly(I:C)CD69+/NKG2D+ NK CellNAmouse model28848054Details
Triple Negative Breast CancerBRCApoly(I:C)CD27- CD11b+ NK CellNAmouse model28848054Details
Triple Negative Breast CancerBRCApoly(I:C)CD27+ CD11b+ NK CellNAmouse model28848054Details
Triple Negative Breast CancerBRCAanti–PD-1 abCD69+ T cellsNAmouse model28848054Details
Triple Negative Breast CancerBRCAanti–PD-1 abCD44+CD62L+ CD8+ T cellsNAmouse model28848054Details
Triple Negative Breast CancerBRCAanti–PD-1 abIFNγ+ CD8+ T CellNAmouse model28848054Details
Breast CancerBRCANewcastle disease virus(NDV)IRF7IRF7clinical trail29504948Details
Breast CancerBRCANewcastle disease virus(NDV)MX2MX2clinical trail29504948Details
Breast CancerBRCANewcastle disease virus(NDV)IFIT2IFIT2clinical trail29504948Details
Breast CancerBRCANewcastle disease virus(NDV)CXCL9CXCL9clinical trail29504948Details
Breast CancerBRCANewcastle disease virus(NDV)CXCL11CXCL11clinical trail29504948Details
Breast CancerBRCAguadecitabineMHC-IINAmouse model29339738Details
Breast CancerBRCAguadecitabineCXCR3CXCR3mouse model29339738Details
Breast CancerBRCAguadecitabineCD8+ T cellsNaive CD8+ T cellmouse model29339738Details
Breast CancerBRCAguadecitabineCD8+ T cellsEffector CD8+ memory T (Tem) cellmouse model29339738Details
Breast CancerBRCAguadecitabineCD8+ T cellsExhausted CD8+ T cellmouse model29339738Details
Breast CancerBRCAguadecitabineCD8+ T cellsCD8+ T cellmouse model29339738Details
Breast CancerBRCAguadecitabineCD8+ T cellsCD8+ cytotoxic T cellmouse model29339738Details
Breast CancerBRCAguadecitabineH2-D1NAmouse model29339738Details
Triple Negative Breast CancerBLCAP53MVAp53-specific CD8+ T cellsNAclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVACD8+T cellsNaive CD8+ T cellclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVACD8+T cellsEffector CD8+ memory T (Tem) cellclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVACD8+T cellsExhausted CD8+ T cellclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVACD8+T cellsCD8+ T cellclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVACD8+T cellsCD8+ cytotoxic T cellclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVACD137+ CD8+ T cellsExhausted CD8+ T cellclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVAPD-1+ CD8+ T cellsExhausted CD8+ T cellclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVACD8+ CD103+ T cellsCD8+ T cellclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVAT-betTBX21clinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVAEomesEOMESclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVAOX40TNFRSF4clinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVACXCR3CXCR3clinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVAIFN-γIFNGclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVACXCL10CXCL10clinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVAKLRG1KLRG1clinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVACTLA-4CTLA4clinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVALAG-3LAG3clinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVATIM-3HAVCR2clinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVATIGITTIGITclinical trial Phase I29209571Details
Triple Negative Breast CancerBLCAP53MVAMAFMAFclinical trial Phase I29209571Details
Breast CancerBRCAdendritic cell-based vaccinationgranzyme BGZMBmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationCD8+ CD107+ T cellsCD8+ cytotoxic T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsT cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsCD4+ T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsCD8+ T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsCytotoxic T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsT helper cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsT helper1 (Th1) cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsT helper2 (Th2) cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsT helper17 (Th17) cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsTransitional B cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsFollicular helper (Tfh) T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsCD4-CD28+ T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsCD4-CD28- T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsActivated CD4+ T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsNaive T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsCentral memory T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsEffector memory T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsEffector T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsAngiogenic T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsNaive CD4+ T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsActivated T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsCD4+CD25+ regulatory T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsCD8+ cytotoxic T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsExhausted T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsT helper9 (Th9) cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsNaive CD8+ T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsMucosal-associated invariant T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsExhausted CD8+ T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsExhausted CD4+ T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationT cellsCD4+ cytotoxic T cellmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationVEGFVEGFAmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationIFN-γIFNGmouse model27497816Details
Breast CancerBRCAdendritic cell-based vaccinationIL-17IL17Amouse model27497816Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ DCsCD16+ dendritic cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ DCsConventional dendritic cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ DCsMyeloid conventional dendritic cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ DCsDendritic cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ DCsPlasmacytoid dendritic cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ DCsMonocyte derived dendritic cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ DCsMyeloid dendritic cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ CD80+ CD40+ cellsB cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ CD80+ CD40+ cellsMyeloid cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ CD80+ CD40+ cellsMyeloid dendritic cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ CD80+ CD40+ cellsPlasmacytoid dendritic cellmouse model27458139Details
HER2-Positive Breast CancerBRCAAd5/3-Δ24-trasCD11c+ CD80+ CD40+ cellsSpecialist antigen presenting cellmouse model27458139Details
Breast CancerBRCAWR.TK-Luc+TregsRegulatory T (Treg) cellmouse model27374223Details
Breast CancerBRCAWR.TK-Luc+TregsNatural regulatory T (Treg) cellmouse model27374223Details
Breast CancerBRCAWR.TK-Luc+TregsCD4+CD25+ regulatory T cellmouse model27374223Details
Breast CancerBRCAWR.TK-Luc+MDSCMyeloid-derived suppressor cellmouse model27374223Details
Breast CancerBRCAVSVΔ51-IFNγpSTAT1STAT1cell lines27119116Details
Breast CancerBRCAVSVΔ51-IFNγMHC-INAcell lines27119116Details
Breast CancerBRCAtrastuzumabMHC-IINAclinical trial30478407Details
Breast CancerBRCAtrastuzumabMHC-IINAmouse model30478407Details